Idexx Laboratories (IDXX) Change in Account Payables (2009 - 2026)

Idexx Laboratories' Change in Account Payables history runs 18 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 238.09% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $10.8 million (up 143.98% YoY), while the FY2025 annual figure was -$8.6 million, down 206.02% from the prior year.
• Change in Account Payables for Q1 2026 stood at $11.2 million, up from -$3.6 million in the prior quarter.
• The five-year high for Change in Account Payables was $11.2 million in Q1 2026, with the low at -$8.1 million in Q1 2025.
• The 5-year median for Change in Account Payables is -$1.5 million (2024), against an average of $802352.9.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 301.11% in 2022, then soared 590.45% in 2025.
• Idexx Laboratories' Change in Account Payables stood at $7.4 million in 2022, then slipped by 15.61% to $6.2 million in 2023, then slipped by 8.06% to $5.7 million in 2024, then tumbled by 162.66% to -$3.6 million in 2025, then soared by 411.93% to $11.2 million in 2026.
• Business Quant data shows IDXX's Change in Account Payables at $11.2 million in Q1 2026, -$3.6 million in Q4 2025, and $7.1 million in Q3 2025.